Back to search
FDAFDA · Food and drugs·Recall number D-1057-2017

Famotidine USP 20 mg, 30 tablets bottle, Rx, PKG By; PD Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 --- NDC 55289-765-30

Published August 9, 2017 · Recall initiated: July 28, 2017

Summary

FDA records drug Class II recall D-1057-2017, published August 9, 2017 and initiated July 28, 2017. Recalling firm: PD-Rx Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 100 bottles; Lot: Lot: A17F55 Exp. 06/30/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specification: out of specification for tablet weight.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
PD-Rx Pharmaceuticals, Inc.
Distributor
Nationwide
Lot
Lot: A17F55 Exp. 06/30/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Famotidine USP 20 mg, 30 tablets bottle, Rx, PKG By; PD Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 --- NDC 55289-765-30 recalled?

Yes. FDA published recall D-1057-2017 on August 9, 2017. Reported hazard: Failed Tablet/Capsule Specification: out of specification for tablet weight.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail